Odoux and colleagues identified CD133+ and CD44+/CD166+/EpCAMHigh cells in samples of metastatic CRC which maintained their CSC marker and histologic phenotypes in a limiting-dilution in vitro culture system as well as in ex vivo xenograft tumor models [65]. This evidence concerns the gene PROM1 and colorectal carcinoma.